Axillary dissection and ductal carcinoma in situ of the breast: A change in practice

Australian and New Zealand Journal of Surgery

Volumn 70, Issue 6, 2000, Pages 419-422

  Kitchen, P R B ^a,b   Cawson, J N ^a   Krishnan, C M ^a   Barbetti, T M ^a   Henderson, M A ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Axillary dissection; Breast carcinoma; Ductal carcinoma in situ

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER INCIDENCE; CARCINOMA IN SITU; CYTOLOGY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0034048215     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1622.2000.01860.x     Document Type: Article

References (22)

1. 1. Delaney G, Ung O, Bilous M et al. Ductal carcinoma in situ part I. Definition and diagnosis. Aust. N.Z. J. Surg. 1997; 67: 81-93.
2. 2. Hansen N, Giuliano A. Axillary dissection for carcinoma in situ. In: Silverstein MJ (ed.) Ductal Carcinoma in Situ of the Breast. Baltimore: Williams & Wilkins, 1997; Ch. 62.
3. 3. Winchester DP, Menck HR, Osteen RT, Kraybill W. Treatment trends for ductal carcinoma in situ of the breast. Ann. Surg. 1995; 2: 207-13.
4. 4. BreastScreen Victoria. 1996 Annual Statistical Report. Melbourne: Victorian BreastScreen Coordination Unit, 1997.
5. 5. Kitchen P, Cawson J, Winch K, Henderson M. Screen-detected breast cancer: The need for proof of invasion prior to axillary dissection (Abstract). Aust. N.Z. J. Surg. Abstract 1998; 68 (Suppl): A34.
6. 6. Kissin MW, Querci della Roveret G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br. J. Surg. 1986; 73: 580-4.
7. 7. Delaney G, Ung O, Bilous M et al. Ductal carcinoma in situ part 2. Treatment. Aust. N.Z. J. Surg. 1997; 67: 157-65.
8. 8. National Health and Medical Research Council. The Management of Early Breast Cancer, Clinical Practice Guidelines, Eastwood NSW: Stone Press, 1995; Ch. 7.
9. 9. Kitchen P, Cawson J, Winch K. Characteristics of minimal invasive breast cancers detected by mammographic screening. Aust. N.Z. J. Surg. 1998; 68: 45-9.
10. 10. Kitchen PRB, Cawson JN. The evolving role of needle cytology and core-biopsy in the diagnosis of breast cancer (Editorial Comment). Aust. N.Z. J. Surg. 1996; 66: 577-9.
11. 11. Serpell JW, Johnson WR. Pre-operative histological diagnosis of breast cancer. Aust. N.Z. J. Surg. 1997; 67: 325-9.
12. 12. Hermann G, Janus C, Schwartz IS, Papatestas A, Herman DG, Rabinowitz JG. Occult malignant breast lesions in relation to age and the presence of microcalcifications. Radiology 1988; 169: 321-4.
13. 13. Tabar L, Dean PB. Teaching Atlas of Mammography, 2nd edn, revised. New York: Thieme-Stratton, 1985.
14. 14. Reiff DB, Cooke J, Griffin M, Given-Wilson R. Ductal carcinoma in situ presenting as a stellate lesion on mammography. Clin. Radiol. 1994; 49: 396-9.
15. 15. Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: Analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989; 172: 235-41.
16. 16. Liberman L, Dershaw DD, Rosen PP et al. Stereotactic biopsy of breast carcinoma: Accuracy at predicting invasion. Radiology 1995; 194: 379-81.
17. 17. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short term treatment failures. Cancer 1982; 50: 1309-14.
18. 18. Patchevsky AS, Schwartz GF, Finkelstein SD et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 731-41.
19. 19. Silverstein MJ. Ductal carcinoma in situ with microinvasion. In: Silverstein MJ (ed.) Ductal Carcinoma in Situ of the Breast. Baltimore: Williams & Wilkins, 1997; Ch. 59.
20. 20. Bembenek A, Reuhl T, Markwardt J, Schneider U, Schlag PM. Sentinel lymph node dissection in breast cancer. Swiss Surg. 1999; 5: 217-21.
21. 21. Cox CE, Pendas S, Cox JM et al. Guidelines for sentinel node biopsy and lymphatic mapping with breast cancer. Ann. Surg. 1998; 227: 645-51.
22. 22. Collins J. How often is the axilla involved: Can primary characteristics predict this? Aust. N.Z. J. Surg. 1998; 68 (Suppl.): A33.